DV
Dividend Vision

CV — CapsoVision, Inc. Common Stock

CapsoVision, Inc. Common Stock (CV)

Total return is 84.6% over the past 1.1 years, 58.1 points ahead of SPY at 26.5%. Its deepest 1-year drawdown was 67.8%.

CapsoVision, Inc. is a medical technology company that manufactures and markets capsule endoscopy systems for visualizing the gastrointestinal tract, including the small bowel and colon, along with related software platforms and reading services for hospitals, clinics, and medical practices. The company does not currently distribute dividends. This security appeals to investors seeking exposure to medical device innovation rather than current income.

CV key facts

Asset type
Stock
Asset class
Equity
Inception date
07/02/2025
Last close
$6.46
Market cap
$335,255,648
Average volume
151800.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.06